-+ 0.00%
-+ 0.00%
-+ 0.00%

ImmunoPrecise Antibodies Q2 EPS $(0.07) Misses $(0.01) Estimate, Sales $4.124M Beat $4.000M Estimate

Benzinga·12/15/2025 13:42:41
Listen to the news
ImmunoPrecise Antibodies (NASDAQ:HYFT) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. This is unchanged from the same period last year. The company reported quarterly sales of $4.124 million which beat the analyst consensus estimate of $4.000 million by 3.10 percent. This is a 53.94 percent increase over sales of $2.679 million the same period last year.